Future Thinking France Launches Pharma Division

SPA Future Thinking's French subsidiary has launched a pharmaceutical healthcare division called Future Thinking Pharma, in Paris, which will be led by Béatrice Chemla, the founder and CEO of healthcare MR agency Listening Pharma.

Future Thinking France was formed as a joint venture in 2011 with French customer relationship specialist Groupe Acticall, and aims to further expand its client roster across Europe with the move into the pharma and healthcare sector.

Future Thinking Pharma will provide a complete range of products and bespoke qual and quant research solutions. Chemla (pictured) began her career at IMS Health LOGIMED, before serving in branding, marketing and product management roles at UCB Pharma, GEHE Pharma Handel, BASF Pharma, Sanofi-Aventis, Sethos, and then setting up Listening Pharma.

Stéphane Marder, CEO at Future Thinking France, comments: 'Strengthening and formalising our healthcare expertise will enable us to offer the pharmaceutical industry unique and innovative tools developed by Quantum Lab, our in-house think tank of new ideas, approaches and products. These tools and analytical techniques have been instrumental in driving our growth in the past two years and have previously been reserved for the FMCG or services sectors.'

Web site: www.futurethinking.fr .